[HTML][HTML] Metallo-β-lactamases: a major threat to human health

EK Phelan, M Miraula, C Selleck, DL Ollis… - American Journal of …, 2014 - scirp.org
Antibiotic resistance is one of the most significant challenges facing global healthcare. Since
the 1940s, antibiotics have been used to fight infections, initially with penicillin and …

Targeting metallo-β-lactamase enzymes in antibiotic resistance

DT King, NCJ Strynadka - Future medicinal chemistry, 2013 - Taylor & Francis
The β-lactam antibiotics are essential for the treatment of a wide range of human bacterial
diseases. However, a class of zinc-dependent hydrolases known as the metallo-β …

An elusive task: a clinically useful inhibitor of metallo-β-lactamases

MM González, AJ Vila - Zinc Enzyme Inhibitors: Enzymes from …, 2017 - Springer
Multidrug-resistant bacterial infections have become in recent years an increasingly
worrisome problem in the medical community. The β-lactams are the most used antibiotics …

Understanding metallo β-lactamases

MI Page - American Society for Microbiology News, 2002 - eprints.hud.ac.uk
The ability to produce ß-lactamase enzymes is the major cause of the resistance of bacteria
to ß-lactam antibiotics. These enzymes catalyze hydrolysis of four-membered ß-lactam rings …

[HTML][HTML] Overcoming differences: The catalytic mechanism of metallo-β-lactamases

MR Meini, LI Llarrull, AJ Vila - FEBS letters, 2015 - Elsevier
Metallo-β-lactamases are the latest resistance mechanism of pathogenic and opportunistic
bacteria against carbapenems, considered as last resort drugs. The worldwide spread of …

Mechanistic Investigations of Metallo‐β‐lactamase Inhibitors: Strong Zinc Binding Is Not Required for Potent Enzyme Inhibition

N Wade, KHME Tehrani, NC Brüchle… - …, 2021 - Wiley Online Library
Abstract Metallo‐β‐lactamases (MBLs) are zinc‐dependent bacterial enzymes that
inactivate essentially all classes of β‐lactam antibiotics including last‐resort carbapenems …

Metallo‐β‐lactamase structure and function

T Palzkill - Annals of the New York Academy of Sciences, 2013 - Wiley Online Library
β‐Lactam antibiotics are the most commonly used antibacterial agents and growing
resistance to these drugs is a concern. Metallo‐β‐lactamases are a diverse set of enzymes …

Inhibiting the metallo-β-lactamases: Challenges and strategies to overcome bacterial β-lactam resistance

MA Jeffs, CT Lohans - Future Medicinal Chemistry, 2022 - Taylor & Francis
Antibiotic resistance & metallo-β-lactamases: a current global issue β-lactams, such as
penicillins, cephalosporins and carbapenems, are currently the most frequently prescribed …

Metallo-β-lactamases: structure, function, epidemiology, treatment options, and the development pipeline

SE Boyd, DM Livermore, DC Hooper… - Antimicrobial agents …, 2020 - Am Soc Microbiol
Modern medicine is threatened by the global rise of antibiotic resistance, especially among
Gram-negative bacteria. Metallo-β-lactamase (MBL) enzymes are a particular concern and …

Principles and current strategies targeting metallo‐β‐lactamase mediated antibacterial resistance

YH Yan, G Li, GB Li - Medicinal Research Reviews, 2020 - Wiley Online Library
Resistance to β‐lactam antibacterials is commonly associated with the production of the
serine β‐lactamases (SBLs) and/or metallo‐β‐lactamases (MBLs). Although clinically useful …